4.7 Article

Extended Liver Resection for Polycystic Liver Disease Can Challenge Liver Transplantation

Journal

ANNALS OF SURGERY
Volume 252, Issue 5, Pages 735-741

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/SLA.0b013e3181fb8dc4

Keywords

-

Categories

Ask authors/readers for more resources

Abbreviations: PLD, polycystic liver disease; PKD, polycystic kidney disease; LT, liver transplantation; LR, liver resection; CT, computed tomography; MRI, magnetic resonance imaging; US, ultrasonography; KT, kidney transplantation; ICU, intensive care unit; POD, postoperative days; INR, prothrombin index; GI, gastrointestinal; HV, hepatic vein; and IVC inferior vena cava. Objective: In an attempt to refine the indications for liver resection (LR) for highly symptomatic polycystic liver disease (PLD), we focused on the characteristics, technical difficulties, postoperative outcome, and long-term follow-up of PLD patients who underwent either LR or liver transplantation (LT). Methods: Since 1995, among 72 patients with massive hepatomegaly, 45 patients underwent LR associated with contralateral cyst fenestration whereas 27 underwent LT associated with simultaneous kidney transplantations in 23. The LR group was characterized by absence of end-stage renal insufficiency, absence of ascites, and better nutrition status. In the LR group, the volumetry of the spared noncystic parenchyma was preoperatively assessed whereas pathological analysis focused on fibrosis and vascular congestion. Results: After LR, the mortality was nil and overall morbidity was 71%, including biliary leak in 20% and ascites in 42%. Persistent and massive ascites was observed in 8 patients who have undergone extensive resection and had significantly more frequently fibrosis on the analysis of their resected surgical specimens (P = 0.002). A volume of the remnant noncystic parenchyma less than 30% and the presence of vascular changes on the specimen were associated with higher risk of complications. The 5-year survival was 95% and among the 43 survivors, after a mean follow-up of 41 months, 36 (83%) patients stated that they were satisfied, with complete relief of symptoms in 30 (70%). After LT, the postoperative mortality was 15% and the overall morbidity was 85%, including 12 patients who required reoperation. Severe complications were more frequent in the presence of denutrition and preoperative ascites. The 5-year survival was 85% and after a mean follow-up of 36 months all survivors had complete relief of symptoms due to hepatomegaly. Conclusions: In case of massive hepatomegaly from PLD without end-stage renal failure, LR should be considered first when preserved remnant liver volume represents at least 30% of the total volume liver in the absence of vascular changes or fibrosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Can we refine the management of blunt liver trauma?

L. Barbier, M. Calmels, M. Lagadec, T. Gauss, P-S Abback, F. Cauchy, M. Ronot, O. Soubrane, C. Paugam-Burtz

JOURNAL OF VISCERAL SURGERY (2019)

Article Anesthesiology

Strategic proposal for a national trauma system in France

Tobias Gauss, Paul Balandraud, Julien Frandon, Julio Abba, Francois Xavier Ageron, Pierre Albaladejo, Catherine Arvieux, Sandrine Barbois, Benjamin Bijok, Xavier Bobbia, Jonathan Charbit, Fabrice Cook, Jean-Stephane David, Guillaume De Saint Maurice, Jacques Duranteau, Delphine Garrigue, Emmanuel Gay, Thomas Geeraerts, Julien Ghelfi, Sophie Hamada, Anatole Harrois, Hicham Kobeiter, Marc Leone, Albrice Levrat, Sebastien Mirek, Abdel Nadji, Catherine Paugam-Burtz, Jean Francois Payen, Sebastien Perbet, Romain Pirracchio, Isabelle Plenier, Julien Pottecher, Sylvain Rigal, Bruno Riou, Dominique Savary, Thierry Secheresse, Karim Tazarourte, Frederic Thony, Jerome Tonetti, Christophe Tresallet, Pierre-Francois Wey, Julien Picard, Pierre Bouzat

ANAESTHESIA CRITICAL CARE & PAIN MEDICINE (2019)

Editorial Material Gastroenterology & Hepatology

Digital pathology: what is the future?

V. Paradis, A. Quaglia

JOURNAL OF HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Combining imaging and tumour biopsy improves the diagnosis of combined hepatocellular-cholangiocarcinoma

Elia Gigante, Maxime Ronot, Caroline Bertin, Maria Ciolina, Mohamed Bouattour, Federica Dondero, Francois Cauchy, Olivier Soubrane, Valerie Vilgrain, Valerie Paradis

LIVER INTERNATIONAL (2019)

Editorial Material Gastroenterology & Hepatology

Liver adenomatosis and NAFLD developed in the context of hereditary fructose intolerance

Lila Ghannem, Aurelie Beaufrere, Jessica Zucman-Rossi, Valerie Paradis

LIVER INTERNATIONAL (2020)

Review Pathology

Hepatocellular adenomas: review of pathological and molecular features

Aurelie Beaufrere, Valerie Paradis

Summary: Hepatocellular adenoma (HCA) is a rare benign liver neoplasm that mainly occurs in women of reproductive age who take oral contraceptives. HCA can be classified into 5 subtypes based on genotype-phenotype characteristics, with the main complications being bleeding and malignant transformation. Management requires a multidisciplinary approach considering gender, tumor size, and HCA subtyping.

HUMAN PATHOLOGY (2021)

Review Gastroenterology & Hepatology

Combined hepatocellular-cholangiocarcinoma: An update

Aurelie Beaufrere, Julien Calderaro, Valerie Paradis

Summary: Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a tumor with both hepatocytic and biliary differentiation, whose diagnosis is primarily based on morphology and immunostaining, with a prognosis worse than hepatocellular carcinoma and treatment limited to surgery.

JOURNAL OF HEPATOLOGY (2021)

Article Oncology

Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features

Jerome Raffenne, Fernando A. Martin, Remy Nicolle, Marina Konta, Yuna Blum, Jerome Torrisani, Francesco Puleo, Jean Baptiste Bachet, Magali Svrcek, Armel Bardier-Dupas, Jean Francois Emile, Peter Demetter, Miroslav Radman, Jean Luc Van Laethem, Pascal Hammel, Vinciane Rebours, Valerie Paradis, Anne Couvelard, Jerome Cros

Summary: Pancreatic ductal adenocarcinoma (PDAC) is typically diagnosed in the 7th decade, but around 10% of patients are diagnosed before the age of 55. Molecular features of early-onset tumors (<= 55 y.o.) were found to be similar to late-onset tumors (>= 70 y.o.), indicating that younger patients can serve as a good molecular surrogate model for the general older population with PDAC. The study also highlighted the impact of ageing on DNA methylation and proteome integrity, as well as the association of oxidative stress responses with PDAC.

CANCERS (2021)

Article Gastroenterology & Hepatology

Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort

Stephen A. Harrison, Samer Gawrieh, Katharine Roberts, Christopher J. Lisanti, Ryan B. Schwope, Katherine M. Cebe, Valerie Paradis, Pierre Bedossa, Jennifer M. Aldridge Whitehead, Aymeric Labourdette, Veronique Miette, Stefan Neubauer, Celine Fournier, Angelo H. Paredes, Naim Alkhouri

Summary: In a cohort of asymptomatic middle-aged Americans, the prevalence of NAFLD was 38%, NASH was 14%, and significant liver fibrosis was present in 6% of the participants.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Hepatocellular Carcinomas: Towards a pathomolecular approach

Valerie Paradis

Summary: The molecular analysis of primary liver malignancies helps refine pathological diagnosis and identify increasing subtypes of hepatocellular proliferation, aiding in patient prognosis and treatment selection. Hepatocellular carcinomas are heterogeneous malignant hepatocellular proliferations, occurring in patients with chronic liver diseases and fibrosis, some arising from malignant transformation of pre-existing hepatocellular adenomas. TERT promoter mutations are common genomic alterations that occur early in liver carcinogenesis, underscoring the importance of a more active biopsy strategy.

LIVER INTERNATIONAL (2021)

Letter Gastroenterology & Hepatology

Reply to: Correspondence regarding Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies

Aurelie Beaufrere, Valerie Vilgrain, Valerie Paradis

JOURNAL OF HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Endothelial autophagy is not required for liver regeneration after partial hepatectomy in mice with fatty liver

Adel Hammoutene, Marion Tanguy, Melanie Calmels, Riccardo Pravisani, Miguel Albuquerque, Christophe Casteleyn, Lotfi Slimani, Jeremy Sadoine, Chantal M. Boulanger, Valerie Paradis, Helene Gilgenkrantz, Pierre-Emmanuel Rautou

Summary: Patients with non-alcoholic fatty liver disease (NAFLD) have impaired liver regeneration due to a defect in autophagy of liver endothelial cells. This study aimed to determine the role of endothelial autophagy in liver regeneration following liver resection in NAFLD.

LIVER INTERNATIONAL (2023)

Review Gastroenterology & Hepatology

Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction

David Nam, Julius Chapiro, Valerie Paradis, Tobias Paul Seraphin, Jakob Nikolas Kather

Summary: Clinical routine in hepatology involves diagnosing and treating various liver diseases. Advances in artificial intelligence have made it possible to extract clinically relevant information from complex clinical datasets, particularly histopathology and radiology data. AI systems have potential as decision support tools in clinical routine, but further clinical validation and regulatory approval are needed.

JHEP REPORTS (2022)

Article Gastroenterology & Hepatology

Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS

Roberto Cannella, Marco Dioguardi Burgio, Aurelie Beaufrere, Loic Trapani, Valerie Paradis, Christian Hobeika, Francois Cauchy, Mohamed Bouattour, Valerie Vilgrain, Riccardo Sartoris, Maxime Ronot

Summary: In this study, the distribution of LI-RADS major features and categories did not differ among different histological subtypes of hepatocellular carcinoma in high-risk patients. However, tumour-in-vein, LR-M features, and ancillary features can provide valuable information for the non-invasive diagnosis of hepatocellular carcinoma subtypes.

JHEP REPORTS (2021)

Article Gastroenterology & Hepatology

ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice

Margaux Sala, Delphine Gonzales, Thierry Leste-Lasserre, Nathalie Dugot-Senant, Valerie Paradis, Sylvaine Di Tommaso, Jean-William Dupuy, Vincent Pitard, Cyril Dourthe, Amedeo Sciarra, Christine Sempoux, Linda D. Ferrell, Andrew D. Clouston, Gregory Miller, Mathew M. Yeh, Swan Thung, Annette S. H. Gouw, Alberto Quaglia, Jing Han, Ji Huan, Cathy Fan, James Crawford, Yasuni Nakanuma, Kenichi Harada, Brigitte le Bail, Claire Castain, Nora Frulio, Herve Trillaud, Laurent Possenti, Jean-Frederic Blanc, Laurence Chiche, Christophe Laurent, Charles Balabaud, Paulette Bioulac-Sage, Anne Aurelie Raymond, Frederic Saltel

HEPATOLOGY COMMUNICATIONS (2020)

No Data Available